ANIXA BIOSCIENCES, INC. Number of Reportable Segments
ANIXA BIOSCIENCES, INC. (ANIX) reported Number of Reportable Segments of 3 Segment for the 9-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Notes
us-gaap:NumberOfReportableSegments · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. number of reportable segments for the quarter ending 2023-01-31 was 4.00 Numbers, a 0.00% change year-over-year.
- ANIXA BIOSCIENCES, INC. number of reportable segments for the quarter ending 2022-01-31 was 4.00 Numbers, a 20.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. number of reportable segments for the quarter ending 2021-01-31 was 5.00 Numbers.
- ANIXA BIOSCIENCES, INC. number of reportable segments for fiscal 2021 was 5.00 Numbers, a 0.00% change from fiscal 2020.
- ANIXA BIOSCIENCES, INC. number of reportable segments for fiscal 2020 was 5.00 Numbers.
Numbers
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2023-01-31 | 4.00 Numbers 10-Q · filed 2023-03-17 | |||
| 2022-07-31 | 4.00 Numbers 10-Q · filed 2022-09-09 | |||
| 2022-04-30 | 4.00 Numbers 10-Q · filed 2022-06-10 | |||
| 2022-01-31 | 4.00 Numbers 10-Q · filed 2022-03-11 | |||
| 2021-10-31 | 5.00 Numbers 10-K · filed 2022-01-04 | |||
| 2021-07-31 | 5.00 Numbers 10-Q · filed 2021-09-01 | |||
| 2021-04-30 | 5.00 Numbers 10-Q · filed 2021-06-10 | |||
| 2021-01-31 | 5.00 Numbers 10-Q · filed 2021-03-11 | |||
| 2020-10-31 | 5.00 Numbers 10-K · filed 2021-01-07 | |||
| 2020-07-31 | 5.00 Numbers 10-Q · filed 2020-09-08 |
pure
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 12 month |
|---|---|---|---|
| 2020-04-30 | 500.00% 10-Q · filed 2020-06-09 | ||
| 2020-01-31 | 300.00% 10-Q · filed 2020-03-09 | ||
| 2019-10-31 | 300.00% 10-K · filed 2020-01-09 | ||
| 2019-04-30 | 300.00% 10-Q · filed 2019-06-12 |
Segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-07-31 | 3.00 Segment 10-Q · filed 2026-09-09 | |||
| 2026-04-30 | 3.00 Segment 10-Q · filed 2026-06-10 | |||
| 2026-01-31 | 3.00 Segment 10-Q · filed 2026-03-09 | |||
| 2025-10-31 | 3.00 Segment 10-K · filed 2026-01-12 | |||
| 2025-01-31 | 3.00 Segment 10-Q · filed 2025-03-11 | |||
| 2024-10-31 | 3.00 Segment 10-K · filed 2025-01-10 | |||
| 2024-07-31 | 3.00 Segment 10-Q · filed 2024-09-06 | |||
| 2022-10-31 | 4.00 Segment 10-K · filed 2023-01-04 |
Segments
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2023-10-31 | 4.00 Segments 10-K · filed 2024-01-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |